Source: ERS Course 2017



Rating:

Share or cite this content

Citations should be made in the following way:
R. Casaburi (Los Angeles, United States of America), A. Neder (Kingston, Canada), P. Laveneziana (Paris, France), S. Ward (Crickhowell, United Kingdom), P. Palange (Rome, Italy). Panel discussion. ERS Course 2017

Member's Comments

No comment yet.

Related content which might interest you: Panel discussion and closing comments Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 Panel discussion and audience Q&A Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome? Year: 2011 Early-Career delegates session - Panel discussion Source: ERS Lung Science Conference 2021 Year: 2021 Application of big data technology for COVID-19: Panel discussion Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Closing remarks and Panel Q&A Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics Year: 2017 Panel discussion: identify concrete areas/topics where collaboration at EU-level is necessary. Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Panel discussion with all involved speakers moderated by the ERS Guidelines Director Source: Annual Congress 2013 –Fellows' Get Together Year: 2013 Session 3: From molecular addiction to therapeutic strategy in NSCLC - Panel discussion Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Formulating recommendations and identifying areas of future research - Panel discussion and protocol Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009